Hypothesis: do homeopathic medicines exert their action in humans and animals via the vomeronasal system?

There is significant debate on the nature of the active therapeutic ingredient in homeopathic medicines and whether the effect of homeopathic medicines is exerted locally. This paper accepts that there is an active therapeutic ingredient in homeopathic medicines that acts pharmacologically in the body and proposes a possible receptor site.

The vomeronasal organ (Jacobson's organ) is the receptor site for the detection of non-odorant molecules, eg pheromones, in reptiles, amphibians and mammals. The organ forms the main part of a chemoreceptor system known as the vomeronasal system. This paper proposes that it is this system that constitutes the receptor for homeopathic medicines in both animal and human subjects.

Keywords

vomeronasal system - Jacobson's organ - solitons - homeopathic receptor site - inactivation by strong odours - homeopathic provings - placebo-controlled trials

• References

• 1 Tschulakow A.V., Yan Y., Klimek W. A new approach to the memory of water. Homeopathy 2005; 94: 241-247.
• 2 Milgrom L.R. Patient-practitioner-remedy (PPR) entanglement. Part 1: a qualitative, non-local metaphor for homeopathy based on quantum theory. Homeopathy 2002; 91: 239-248.
• 3 Jacobson L. Description anatomique d’un organe observe dans les mammiferes. Ann Mus Hist Nat Paris 1811; 18: 412-424.
• 4 Hahnemann S. Organon of the Medical Art. Sixth edition. Edited and annotated by Wenda Brewster O’Reilly, based on the translation by Steven Decker. Washington: Birdcage Books, 1996, Paragraphs 105–145, pp 270, 284.
• 5 Hahnemann S. Organon of Homeopathic Medicine. Third American edition. New York: William Radde; 1849. subnote to Paragraph 288
• 6 Dante F., Fisher P. A systematic review of homeopathic pathogenetic trials (‘provings’) published in the United Kingdom from 1945 to 1995. Ernst E., Eckhart G.H. Homeopathy A Critical Appraisal. 1998. Oxford: Butterworth Heinemann; 69-97
• 7 Sherr J. The Dynamics of Homeopathic Provings. Second edition. Malvern, England: Dynamis Books; 1994. p 33
• 8 Gemmell D. Everyday Homeopathy. A Safe Guide to Self-treatment. Beaconsfield, England: Beaconsfield Publishers Ltd.; 1987. p 8
• 9 Hahnemann S. Organon of Homeopathic Medicine. Third American edition. New York: William Radde; 1849. subnote to Paragraph 260
• 10 Lledo P.M., Gheusi G., Vincent J.D. Information processing in the mammalian olfactory system. Physiol Rev 2005; 85: 281-317.
• 11 Dulac C., Axel R. A novel family of genes encoding putative pheromone receptors in mammals. Cell 1995; 83: 195-206.
• [12] Matsunami H, Buck L.B. A multigene family encoding a diverse array of putative pheromone receptors in mammals. Cell 1997; Aug 22;90 (4):775–81.
• 13 O’Connell R.J., Meredith M. Effects of volatile and non-volatile chemical signals on male sex behaviours mediated by the main and accessory olfactory systems. Behav Neurosci 1984; 98: 1083-1093.
• 14 Brennan P.A., Keverne F.B. Something in the air? New insights into mammalian pheromones. Curr Biol 2004; 14: R81-R89.
• 15 Baxi K.N., Dorries K.M., Eisthen H.L. Is the vomeronasal system really specialised for sensing pheromones?. Trends Neurosci 2006; 29: 1-7 [Epub.2005 November 3]
• 16 Trinh K., Storm D.R. Detection of odorants through the main olfactory epithelium and the vomeronasal organ of mice. Nutr Rev 2004; 62 pt 2 189-192 S224–S241 [review]
• 17 Monti-Bloch L., Jennings-White C., Dolberg D.S., Berliner D.L. The human vomeronasal system. Psychoneuro-endocrinology 1994; 19: 673-686.
• 18 Potiquet M. Le canal de Jacobson. Rev Laryngol (Paris) 1891; 2: 737-753.
• 19 Meredith M. Chronic recording of vomeronasal pump activation in awake behaving hamsters. Physiol Behav 1994; 56: 345-354.
• 20 Leinders-Zufall T., Lane A.P., Puche A.C. et al. Ultrasensitive pheromone detection by mammalian vomeronasal neurons. Nature 2000; 405: 792-796.
• 21 Fleischer J., Schwarzenbacher K., Besser S., Hass N., Breer H. Olfactory receptors and signalling elements in the Grueneberg ganglion. J Neurochem 2006; 98: 543-554.
• 22 Wirsig-Wiechmann C.R. Function of gonadotrophin releasing hormone in olfaction. Keio J Med 2001; 50: 81-859.
• 23 Zhang J., Webb D.M. Evolutionary deterioration of the vomeronasal pheromone transduction pathway in catarrhine primates. Proc Natl Acad Sci USA 2003; 100: 8337-8341 [Epub 2003 June 25]
• 24 Gilad Y., Wiebe V., Przeworski M., Lancet D., Paabo S. Loss of olfactory receptor genes coincides with the acquisition of full trichromatic vision in primates. PLosBiol 2004: E5 [Epub 2004 January 20]
• 25 Smith T.D., Bhatnagar K.P., Shimp K.L. et al. Histological definition of the vomeronasal organ in humans and chimpanzees, with a comparison to other primates. Anat Rec 2002; 267: 166-176.
• 26 Boehm N., Gasser B. Sensory receptor-like cells in the human fetal vomeronasal organ. Neuroreport 1993; 4: 867-870.
• 27 Smith T.D., Siegel M.I., Mooney M.P., Burdi A.R. et al. Prenatal growth of the human vomeronasal organ. Anat Rec 1997; 248: 447-455.
• 28 Trotier D., Eloit C., Wassef M., Talmain G. et al. The vomeronasal cavity in adult humans. Chem Senses 2000; 25: 369-380.
• 29 Abolmaali N.D., Kuhnau D., Knecht M., Kohler K., Huttenbrink K.B., Hummel T. Imaging of the human vomeronasal duct. Chem Senses 2001; 26: 35-39.
• 30 Stensaas L.J., Lavker R.M., Monti-Bloch L., Grosser B.I., Berliner D.L. Ultrastructure of the human vomeronasal organ. J Steroid Biochem Mol Biol 1991; 39: 553-560.
• 31 Meisami E., Bhatnagar K.P. Structure and diversity in the mammalian accessory olfactory bulb. Microsc Res Tech 1998; 43: 476-499.
• 32 Monti-Bloch L., Jennings-White C., Berliner D.L. The human vomeronasal system. A review. Ann NY Acad Sci 1998; 855: 373-389.
• 33 Bokil H., Laaris N., Blinder K., Ennis M., Keller A. Ephaptic interactions in the mammalian olfactory system. J Neurosci 2001; 21: RC173.
• 34 Bliss T.V.P., Rosenberg M.E. Activity-dependent changes in conduction velocity in the olfactory nerve of the tortoise. Pflugers Arch 1979; 381: 209-216.
• 35 Breer H., Shepherd G.M. Implications of the NO-cGMP system of olfaction. Trends Neurosci 1993; 16: 5-9.
• 36 McClintock M.K. Menstrual synchrony and suppression. Nature 1971; 229: 244-245.
• 37 Stern K., McClintock M.K. Regulation of ovulation by human pheromones. Nature 1998; 392: 177-179.
• 38 Monti-Bloch L., Grosser B.I. Effect of putative pheromones on the electrical activity of the human vomeronasal organ and olfactory epithelium. J Steroid Biochem Mol Biol 1991; 39: 573-582.
• 39 Monti-Bloch L., Diaz-Sanchez V., Jennings-White C., Berliner D.L. Modulation of serum testosterone and autonomic function through stimulation of the male human vomeronasal organ (VNO) with pregna-4, 20-diene-3,6-dione. J Steroid Biochem Mol Biol 1998; 65: 237-242.
• 40 Meredith M. Human vomeronasal organ function: a critical review of best and worst cases. Chem Senses 2001; 26: 433-445.
• 41 Sobel N., Prabhakaran V., Hartley C.A. et al. Blind smell: brain activation induced by an undetected air-borne chemical. Brain 1999; 122 Pt. 2 209-217.
• 42 Winans S.S., Scalia F. Amygdaloid nucleus: new afferent input from the vomeronasal organ. Science 1970; 170: 330-332.
• 43 Berghard A., Buck L.B. Sensory transduction in vomeronasal neurons: evidence for G alpha o, G alpha i2, and adenylyl cyclase II as major components of a pheromone signalling cascade. J Neurosci 1996; 16: 909-918.
• 44 Webb D.M., Cortes-Ortiz L., Zhang J. Genetic evidence for the coexistence of pheromone perception and full trichromatic vision in howler monkeys. Mol Biol Evol 2004; 21: 697-704 [Epub 2004 February]
• 45 Angioy A.M., Desogus A., Tomassini B.I., Anderson P., Hansson W.S. Extreme sensitivity in an olfactory system. Chem Senses 2003; 28: 279-284.
• 46 Sumper M., Berg E., Wenzl S., Godl K. How a sex pheromone might act at a concentration below 10(-16)M. EMBO J 1993; 12: 831-836.
• 47 Reilly D.T. Is homeopathy a placebo response? What if it is? What if it is not?. Ernst E., Hahn E.G. Homeopathy, A Critical Appraisal. 1998. Oxford: Butterworth Heinemann;
• 48 Reilly D.T., Taylor M.A. Developing integrated medicine. Report of the RCCM Research Fellowship in Complementary Medicine, Glasgow University 1987–1990. Complementary Ther Med 1993; 1 (Suppl. 01) 1-49.
• 49 Lundsrom J.N., Hummel T., Olsson M.J. Individual differences in sensitivity to the odor of 4,16-androstadien-3-one. Chem Senses 2003; 28: 643-650.
• 50 Wysocki C.J., Dorries K.M., Beauchamp G.K. Ability to perceive androstenone can be acquired by ostensibly anosmic people. Proc Natl Acad Sci USA 1989; 86 (20) 7976-7978.
• 51 Hahnemann S. The Organon of Medicine. Fifth edition. London: Hahnemann Publishing Society; 1893. Paragraph 291
• 52 Sanhueza M., Schmachtenberg O., Bacigalupo J. Excitation, inhibition and suppression by odors in isolated toad and rat olfactory receptor neurons. Am J Physiol Cell Physiol 2000; 279: C31-C39.
• 53 Restrepo D., Arellano J., Oliva A.M., Schaefer M.L., Lin W. Emerging view on the distinct but related roles of the main and accessory olfactory systems in responsiveness to chemosensory signals in mice. Horm Behav 2004; 46: 247-256.
• 54 Bensafi M, Frasnelli J, Reden J, Hummel T. The neural representation of odour is modulated by the presence of a trigeminal stimulus during odour encoding. Clin Neurophysiol 2007 January 5 [Epub ahead of print].
• 55 Swayne J. Homeopathic Method. Edinburgh: Churchill Livingstonem; 1998. pp 106–107, 180–181
• 56 Westervelt H.J., Stern R.A., Tremont G. Odor identification deficits in diffuse lewy body disease. Cogn Behav Neurol 2003; 16: 93-99.
• 57 Monti-Bloch L., Grosser B.I. Effect of putative pheromones on the electrical activity of the human vomeronasal organ and olfactory epithelium. J Steroid Biochem Mol Biol 1991; 39: 573-582.